Fructooligosaccharides Ameliorating Cognitive Deficits and Neurodegeneration in APP/PS1 Transgenic Mice through

Jing Sun1, Suzhi Liu2, Zongxin Ling3

  • 1Department of Neurology , the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University , Wenzhou , Zhejiang 325027 , China.

Insights

Prebiotic fructooligosaccharides (FOS) improve cognition and reduce Alzheimer's disease pathology by modulating gut bacteria and the gut microbiota-GLP-1/GLP-1R pathway.

Area of Science:

  • Neuroscience
  • Microbiology
  • Pharmacology

Background:

  • Alzheimer's disease (AD) is linked to changes in gut microbiota.
  • Prebiotics like fructooligosaccharides (FOS) can regulate gut bacteria.
  • Understanding FOS's protective mechanisms against AD is crucial.

Purpose of the Study:

  • To investigate the protective effects of FOS against Alzheimer's disease (AD) in a mouse model.
  • To explore the underlying mechanisms involving gut microbiota modulation and the GLP-1/GLP-1R pathway.

Main Methods:

  • Administered FOS to male APP/PS1 transgenic mice for 6 weeks.
  • Assessed cognitive function, amyloid deposition, synaptic plasticity markers (PSD-95, synapsin I), and JNK phosphorylation.
  • Analyzed gut microbial composition using 16S rRNA sequencing.
  • Measured gut glucagon-like peptide-1 (GLP-1) and brain GLP-1 receptor (GLP-1R) levels.

Main Results:

  • FOS treatment improved cognitive deficits and reduced amyloid pathology in transgenic mice.
  • FOS upregulated synaptic plasticity markers (synapsin I, PSD-95) and decreased JNK phosphorylation.
  • FOS altered gut microbial composition towards a healthier state.
  • FOS increased GLP-1 levels in the gut and affected GLP-1R levels in the brain.

Conclusions:

  • Fructooligosaccharides (FOS) demonstrate beneficial effects in an Alzheimer's disease mouse model.
  • FOS exerts neuroprotection by regulating gut microbiota composition.
  • The gut microbiota-GLP-1/GLP-1R signaling pathway is a key mechanism for FOS's therapeutic action in AD.

Related Concept Videos

Transgenic Organisms00:53

Transgenic Organisms

Overview
33.4K
Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
896
Transgenic Plants02:50

Transgenic Plants

Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
8.7K